<div id="readability-page-1"><div>Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The &#34;Retinal Surgery Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033&#34; has been added to ResearchAndMarkets.com's offering.The Retinal Surgery Devices Market is expected to reach US$ 4.84 billion in 2033 from US$ 2.48 billion in 2024, with a CAGR of 7.71% from 2025 to 2033. Some of the main reasons propelling the market include the rising prevalence of a number of eye ailments, increased awareness of eye issues and available treatments, and the expanding use of minimally invasive (MI) surgical technology. Rising prevalence of retinal diseasesThe market for retinal surgery instruments is mostly driven by the increasing incidence of retinal disorders. Age-related macular degeneration (AMD), diabetic retinopathy, and retinal detachment are among the conditions that are growing increasingly prevalent, especially as the world's population ages and the prevalence of diabetes rises. The need for sophisticated retinal surgery equipment, including lasers, vitrectomy tools, and surgical microscopes, is increasing since these conditions frequently call for surgical intervention. The demand for specialist surgical instruments is boosted by more surgeries performed as a result of early diagnosis and greater awareness of these disorders. Market growth and innovation in the industry are still being propelled by this trend.Around 2.2 billion people worldwide suffer from near or distant vision impairment, of which nearly 1 billion cases may have been avoided, according to a WHO report published in October 2021. It demonstrates the high prevalence of visual impairment patients globally as well as the potential for therapy. Because of this, the demand for ophthalmic medications is quite high, which will favorably affect the market's growth over the study's projected period.Increasing Geriatric PopulationOne major factor propelling the market for retinal surgery instruments is the aging population. People are more vulnerable to age-related retinal disorders include diabetic retinopathy, macular degeneration, and retinal detachment as they get older. By 2050, there will be about 2 billion people worldwide who are 60 years of age or older, up from 900 million in 2015, according to figures from the World Health Organization (WHO) in 2021. Approximately 125 million people are 80 years of age or older at the moment.</div><div>Furthermore, advancements in less invasive procedures like improved optical coherence tomography (OCT) and microincision vitrectomy shorten recovery times and boost patient outcomes. These developments enable more effective therapies as well as earlier and more precise diagnosis. The market for retinal surgery devices is growing as a result of increasingly sophisticated, patient-friendly solutions brought about by ongoing technological advancements. For instance, in April 2022, the next-generation canaloplasty tool, iTrack Advance, announced that it will be available in a few European and Asia Pacific markets, according to Nova Eye Medical.High CostThe market for retinal surgery devices is severely hampered by high cost. Due to their high cost, advanced surgical tools and technologies - like lasers and imaging systems - are not widely available, especially in low- and middle-income nations. This may cause therapy to be delayed or insufficient since it is difficult for medical professionals in these areas to afford the newest technology. Furthermore, the exorbitant cost of gadgets may raise total treatment costs, restricting patient access and taxing healthcare systems.Regulatory BarriersThe market for retinal surgery devices is hampered by regulatory constraints because of the rigorous approval procedures that regulatory agencies like the FDA and EMA demand. Long product launch timeframes are a result of these procedures, which frequently entail thorough clinical trials, safety testing, and adherence to particular manufacturing standards. The intricacy of fulfilling these regulations can hinder market access, raise costs for manufacturers, and postpone the release of novel devices - especially for startups or businesses expanding into untapped markets.Due to its ability to treat a variety of retinal disorders, vitrectomy machines are essential in the market for retinal surgery devicesVitrectomy machines represented the largest segment. These machines facilitate the elimination of vitreous gel debris or blood during surgical operations, addressing situations such as retinal detachment, diabetic retinopathy, and macular holes. Their superior functions, combined with dual-port systems and microincision technology, enhance maneuverability and expedite recovery. This makes vitrectomy machines indispensable for retinal surgeons to deliver effective remedies and improve patient outcomes.Diabetic retinopathy is booming in the retinal surgery device market due to rising diabetesThe International Diabetes Federation (IDF) predicts that 463 million adults aged 20-79 will have diabetes. By 2045, it'll rise to 700 million, and 79% will be from low- and middle-income countries. As diabetes rates increase, so does the occurrence of diabetic retinopathy, a common hardship that could cause imaginative and prescient impairment or blindness if left untreated. Consequently, there is a growing demand for retinal surgical devices, including vitrectomy machines, to control diabetic retinopathy effectively, propelling the growth of this section in the market.Hospitals dominate the market as primary centers for surgery and patient careHospitals accounted for a considerable market share. Equipped with superior facilities and specialized understanding, hospitals provide a comprehensive variety of retinal surgery devices, which include diagnostics, surgical interventions, and post-operative care. Hospitals also offer a conducive environment for surgeons to utilize cutting-edge retinal surgical treatment devices successfully, ensuring the most remarkable patient outcomes. Their vital function in healthcare devices solidifies hospitals as critical players in the retinal surgery device market.Retinal Surgery Devices Market Overview by RegionsNorth America leads the world market for retinal surgery devices because of its high adoption rates and sophisticated healthcare infrastructure. Europe comes next, propelled by advances in technology and aging populations. The growing prevalence of retinal disorders in emerging nations and improved access to healthcare are driving Asia-Pacific's rapid expansion.United States Retinal Surgery Devices MarketThe increasing incidence of retinal disorders such age-related macular degeneration, diabetic retinopathy, and retinal detachment is propelling the market for retinal surgery devices in the United States. The need for sophisticated surgical devices including lasers, vitrectomy tools, and surgical microscopes is growing as a result of the aging population and growing awareness of retinal health. Further driving market expansion are technological developments in retinal surgery, such as less invasive techniques and improved imaging systems. The United States is a major player in the global market for retinal surgery devices because of its strong healthcare system and favorable reimbursement laws.In April 2022, Parkhurst NuVision introduced EVO Visian ICL, a novel vision device, in the US following FDA approval.Germany Retinal Surgery Devices MarketDue to the high frequency of retinal diseases such age-related macular degeneration and diabetic retinopathy, the market for retinal surgery devices in Germany is growing. Market expansion is supported by the nation's sophisticated healthcare system, highly qualified medical staff, and use of cutting-edge surgical technologies including lasers and high-resolution imaging. The need for specialist retinal surgery equipment is also fueled by Germany's aging population and growing awareness of retinal health. Innovation and commercial expansion in the region are also fueled by government programs and a significant emphasis on research and development.India Retinal Surgery Devices MarketThe growing prevalence of retinal illnesses such as diabetic retinopathy, macular degeneration, and retinal detachment - especially as a result of increased diabetes rates - is driving the market for retinal surgery devices in India. Advanced retinal surgery equipment like lasers, vitrectomy tools, and surgical microscopes are in high demand due to the nation's aging population and developing healthcare system. Adoption of specialized treatments is aided by increased knowledge about retinal health and early diagnosis availability. Furthermore, government programs and growing disposable incomes are making these gadgets more accessible, which is opening up a lot of market expansion prospects, particularly in urban and semi-urban areas.UAE Retinal Surgery Devices MarketDue to the rising incidence of retinal conditions such diabetic retinopathy and macular degeneration, the market for retinal surgery devices in the United Arab Emirates is expanding. Growing awareness of eye health, the nation's sophisticated healthcare system, and a thriving medical tourism industry all support market expansion. Further driving demand for improved retinal surgery tools, such as lasers, vitrectomy instruments, and surgical microscopes, are the aging population and the growing availability of specialized treatments.</div><div>Key Topics Covered1. Introduction2. Research Methodology3. Executive Summary4. Market Dynamics 4.1 Growth Drivers 4.2 Challenges5. Retinal Surgery Devices Market6. Market Share 6.1 By Product 6.2 By Application 6.3 By End User 6.4 By Countries7. Product 7.1 Vitrectomy Machines 7.2 Vitrectomy Packs 7.3 Surgical Instruments 7.4 Microscopic Illumination Equipment 7.5 Retinal Laser Equipment 7.6 Others8. Application 8.1 Diabetic Retinopathy 8.2 Retinal Detachment 8.3 Epiretinal Membrane 8.4 Macular Hole 8.5 Others9. End User 9.1 Hospitals 9.2 Eye Clinics 9.3 Others10. Countries 10.1 North America 10.1.1 United States 10.1.2 Canada 10.2 Europe 10.2.1 France 10.2.2 Germany 10.2.3 Italy 10.2.4 Spain 10.2.5 United Kingdom 10.2.6 Belgium 10.2.7 Netherland 10.2.8 Turkey 10.3 Asia-Pacific 10.3.1 China 10.3.2 Japan 10.3.3 India 10.3.4 South Korea 10.3.5 Thailand 10.3.6 Malaysia 10.3.7 Indonesia 10.3.8 Australia 10.3.9 New Zealand 10.4 Latin America 10.4.1 Brazil 10.4.2 Mexico 10.4.3 Argentina 10.5 Middle East &amp; Africa 10.5.1 Saudi Arabia 10.5.2 UAE 10.5.3 South Africa11. Porter's Five Forces 11.1 Bargaining Power of Buyers 11.2 Bargaining Power of Suppliers 11.3 Degree of Rivalry 11.4 Threat of New Entrants 11.5 Threat of Substitutes12. SWOT Analysis 12.1 Strength 12.2 Weakness 12.3 Opportunity 12.4 Threat13. Key Players Analysis</div>For more information about this report visit https://www.researchandmarkets.com/r/tep29rAbout ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.</div>

愛爾康

7732

視網膜手術設備市場預計將從 2024 年的 24.8 億美元增長到 2033 年的 48.4 億美元，年均增長率為 7.71%。主要驅動因素包括視網膜疾病的發病率上升、老齡化人口以及微創手術技術的進步。然而，高昂的成本和監管障礙帶來了挑戰。玻璃體切除機在市場中佔據主導地位，對於治療如糖尿病視網膜病變等因糖尿病發病率上升而日益增加的疾病至關重要。隨着意識和早期診斷的改善，對專業手術器械的需求預計將增長

Retinal Surgery Devices Market Outlook Report 2025-2033: Revenues Set to Double, Reaching $4.83 Billion by 2033, Led by Topcon Corp., Alcon, and Carl Zeiss

視網膜手術設備市場展望報告 2025-2033：收入預計將翻倍，到 2033 年達到 48.3 億美元，主要由拓普康公司、愛爾康和卡爾蔡司公司引領